Your browser doesn't support javascript.
loading
High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial.
Cresswell, Fiona V; Meya, David B; Kagimu, Enock; Grint, Daniel; Te Brake, Lindsey; Kasibante, John; Martyn, Emily; Rutakingirwa, Morris; Quinn, Carson M; Okirwoth, Micheal; Tugume, Lillian; Ssembambulidde, Kenneth; Musubire, Abdu K; Bangdiwala, Ananta S; Buzibye, Allan; Muzoora, Conrad; Svensson, Elin M; Aarnoutse, Rob; Boulware, David R; Elliott, Alison M.
Afiliação
  • Cresswell FV; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom.
  • Meya DB; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Kagimu E; Medical Research Council - Uganda Virus Research Institute - LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Grint D; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Te Brake L; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Kasibante J; Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom.
  • Martyn E; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Centre, The Netherlands.
  • Rutakingirwa M; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Quinn CM; Clinical Research Department, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom.
  • Okirwoth M; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Tugume L; University of California, San Francisco, San Francisco, California, USA.
  • Ssembambulidde K; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Musubire AK; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Bangdiwala AS; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Buzibye A; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Muzoora C; Division of Biostatistics, University of Minnesota, Minneapolis, Minneapolis, Minnesota, USA.
  • Svensson EM; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Aarnoutse R; Mbarara University of Science and Technology, Mbarara, Uganda.
  • Boulware DR; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Centre, The Netherlands.
  • Elliott AM; Department of Pharmacy, Uppsala University, Sweden.
Clin Infect Dis ; 73(5): 876-884, 2021 09 07.
Article em En | MEDLINE | ID: mdl-33693537
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Meníngea / Infecções por HIV Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Meníngea / Infecções por HIV Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article